The Marine Natural Compound Aplysinamisine I Selectively Induces Apoptosis and Exhibits Synergy with Taxol™ in Triple-Negative Breast Cancer Spheroids
Marine Drugs · 2025
DOI: 10.3390/md23100380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Esther A Guzmán und 3 weiteren Autor:innen. Beteiligte Einrichtung: Marine Biomedical and Biotechnology Research, Harbor Branch Oceanographic Institute, Florida Atlantic University, 5600 US 1 North, Fort Pierce, FL 34…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Apoptosis, Paclitaxel, Porifera. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Oceanic and Atmospheric Administration, Harbor Branch Oceanographic Institute Foundation.
Abstract (Originalsprache)
Triple-negative breast cancers (TNBC) lack estrogen, progesterone, and express little, if any, HER2 receptors on their surface. No targeted therapies exist for this aggressive form of breast cancer. A library of enriched fractions from marine organisms was screened in a multi-parametric cytotoxicity assay using MDA-MB-231 and MDA-MB-468 TNBC cells, grown as spheroids (3D cultures). Spheroids better resemble tumors and are considered more clinically predictive. The assay measures apoptosis via the cleavage of caspase 3/7, viability via DNA content, and loss of membrane integrity via 7AAD staining at 24 h of treatment. Fractions were also tested in a traditional 2D MTT assay at 72 h. A fraction from the sponge Aplysina was active in the 3D assay. Aplysinamisine I was identified as the compound responsible for the activity. Aplysinamisine I induces apoptosis in MDA-MB-268 spheroids with an IC50 of 2.9 ± 0.28 µM at 24 h. This novel activity is the most potent for the compound to date. Its IC50 in the MTT assay at 72 h is >80 µM. Striking synergy with Taxol™ is shown in both cell lines. Proteomic analysis led to a differential protein expression profile. Through bioinformatics, this profile led to the hypothesis that the inhibition of nucleophosmin is the potential mode of action of the compound. However, initial studies show only a modest decrease in nucleophosmin expression in spheroids treated with aplysinamisine I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marine Biomedical and Biotechnology Research, Harbor Branch Oceanographic Institute, Florida Atlantic University, 5600 US 1 North, Fort Pierce, FL 34946, USA.
ORCID-Profile: Esther A Guzmán, Amy E Wright
Förderung
- NCI NIH HHS
- National Oceanic and Atmospheric Administration
- Harbor Branch Oceanographic Institute Foundation
- Florida Department of Health Bankhead Coley
- Research Excellence Funds
- NCI
- NOAA
Zitieren
APA
Guzmán, E. A., Peterson, T. A., Harmody, D. K., & Wright, A. E. (2025). The Marine Natural Compound Aplysinamisine I Selectively Induces Apoptosis and Exhibits Synergy with Taxol™ in Triple-Negative Breast Cancer Spheroids. Marine Drugs. https://doi.org/10.3390/md23100380
Vancouver
Guzmán EA, Peterson TA, Harmody DK, Wright AE. The Marine Natural Compound Aplysinamisine I Selectively Induces Apoptosis and Exhibits Synergy with Taxol™ in Triple-Negative Breast Cancer Spheroids. Marine Drugs. 2025. doi:10.3390/md23100380
BibTeX
@article{Guzmn2025,
author = {Guzmán, Esther A and Peterson, Tara A and Harmody, Dedra K and Wright, Amy E},
title = {The Marine Natural Compound Aplysinamisine I Selectively Induces Apoptosis and Exhibits Synergy with Taxol™ in Triple-Negative Breast Cancer Spheroids},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23100380}
}
EUVIMED